Quick Takeaways
- David E. Lazar filed SCHEDULE 13D for KALA BIO, Inc. Common Stock, $0.001 par value (KALA).
- Disclosed ownership: 5.2%.
- Date of event: 30 Jan 2026.
David E. Lazar - 30 Jan 2026 SCHEDULE 13D Report for KALA BIO, Inc. Common Stock, $0.001 par value (KALA)
- Filing Manager
- David E. Lazar
- Reporting Manager
- David E. Lazar
- Symbol
- KALA
- Shares outstanding
- 955,598,456 shares
- Disclosed Ownership
- 49,500,000 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13D
- Filing time
- 06 Feb 2026, 16:14:44 UTC
- Date of event
- 30 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"David E. Lazar disclosed 5.2% ownership in KALA BIO, Inc. Common Stock, $0.001 par value (KALA) on 30 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Feb 2026, 16:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| David E. Lazar | 5.2% | 49,500,000 | 49,500,000 | 0 | /s/ David E. Lazar | David E. Lazar | 0001932843 |